JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moreno, O. M.
Right arrow Articles by Brodie, D. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moreno, O. M.
Right arrow Articles by Brodie, D. A.
Journal of Pharmacology And Experimental Therapeutics, Vol. 135, Issue 2, 259-264, 1962
Copyright © 1962 by American Society for Pharmacology and Experimental Therapeutics


EFFECTS OF DRUGS ON GASTRIC HEMORRHAGES PRODUCED BY THE ADMINISTRATION OF POLYMYXIN B

Oscar M. Moreno 1 and David A. Brodie 1

1 Merck Institute for Therapeutic Research, West Point, Pennsylvania

Two hours following the subcutaneous injection of 10.0 mg/kg Polymyxin B, a histamine liberator, 90% of the rats tested had gastric hemorrhages. Epinephrine was the most effective agent tested for prevention of the gastric lesions. Antihistaminics such as cyproheptadine, chlorpheniramine and pyrilamine were also active. Chlorpromazine and Dibenzyline were active but required high doses to provide protection. Anticholinergic drugs and an antacid were not effective against the Polymyxin B lesions. The pharmacological data, combined with experiments on the effect of Polymyxin B on gastric secretion, indicated that the production of lesions was due to gastric vascular changes with no involvement of the gastric secretory mechanism. The data also suggest that drug antagonism of Polymyxin B gastric lesions can be ascribed to a general effect of the drugs on the cardiovascular action of released histamine rather than to the direct antagonistic effect on the gastric vasculature.

Submitted on July 17, 1961







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1962 by the American Society for Pharmacology and Experimental Therapeutics.